National Products Association To Supreme Court: Risk-Benefit Standard Would “Unravel” Dietary Supplement Act

FDA's risk-benefit standard to determine product adulteration violates Dietary Supplement Health and Education Act "and poses a significant threat" to dietary supplement firms, trade group says in amicus curiae brief.

More from Archive

More from Pink Sheet